{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:35:11Z","timestamp":1793928911691,"version":"4.8.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100001796","name":"Gustavus and Louise Pfeiffer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001796","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-61114-4","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:45:30Z","timestamp":1751377530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Budesonide-incorporated inhalable lipid nanoparticles for antiTSLP nanobody mRNA delivery to treat steroid-resistant asthma"],"prefix":"10.1038","volume":"16","author":[{"given":"Jia","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1634-3329","authenticated-orcid":false,"given":"Xiaoyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4954-2586","authenticated-orcid":false,"given":"Xue-Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"61114_CR1","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/S0140-6736(22)02125-0","volume":"401","author":"C Porsbjerg","year":"2023","unstructured":"Porsbjerg, C. et al. Asthma. Lancet 401, 858\u2013873 (2023).","journal-title":"Lancet"},{"key":"61114_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ni.3049","volume":"16","author":"B Lambrecht","year":"2015","unstructured":"Lambrecht, B. & Hammad, H. The immunology of asthma. Nat. Immunol. 16, 45\u201356 (2015).","journal-title":"Nat. Immunol."},{"key":"61114_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40820-x","volume":"14","author":"EK van der Ploeg","year":"2023","unstructured":"van der Ploeg, E. K. et al. Type-2 CD8+ T-cell formation relies on interleukin-33 and is linked to asthma exacerbations. Nat. Commun. 14, 5137 (2023).","journal-title":"Nat. Commun."},{"key":"61114_CR4","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nrd3792","volume":"11","author":"G Pelaia","year":"2012","unstructured":"Pelaia, G., Vatrella, A. & Maselli, R. The potential of biologics for the treatment of asthma. Nat. Rev. Drug Discov. 11, 958\u2013972 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"61114_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrm.2016.152","volume":"18","author":"E Weikum","year":"2017","unstructured":"Weikum, E. et al. Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat. Rev. Mol. Cell Biol. 18, 159\u2013174 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"61114_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nri.2017.1","volume":"17","author":"D Cain","year":"2017","unstructured":"Cain, D. & Cidlowski, J. Immune regulation by glucocorticoids. Nat. Rev. Immunol. 17, 233\u2013247 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"61114_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07698-6","volume":"9","author":"CC Campa","year":"2018","unstructured":"Campa, C. C. et al. Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis. Nat. Commun. 9, 5232 (2018).","journal-title":"Nat. Commun."},{"key":"61114_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14937","volume":"8","author":"K Verstraete","year":"2017","unstructured":"Verstraete, K. et al. Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma. Nat. Commun. 8, 14937 (2017).","journal-title":"Nat. Commun."},{"key":"61114_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41577-022-00735-y","volume":"23","author":"R Ebina-Shibuya","year":"2023","unstructured":"Ebina-Shibuya, R. & Leonard, W. J. Role of thymic stromal lymphopoietin in allergy and beyond. Nat. Rev. Immunol. 23, 24\u201337 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"61114_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nri2275","volume":"8","author":"H Hammad","year":"2008","unstructured":"Hammad, H. & Lambrecht, B. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat. Rev. Immunol. 8, 193\u2013204 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"61114_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44168-0","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Cullin5 drives experimental asthma exacerbations by modulating alveolar macrophage antiviral immunity. Nat. Commun. 15, 252 (2024).","journal-title":"Nat. Commun."},{"key":"61114_CR12","doi-asserted-by":"publisher","first-page":"100969","DOI":"10.1016\/j.mam.2021.100969","volume":"85","author":"G Caramori","year":"2022","unstructured":"Caramori, G., Nucera, F., Mumby, S., Lo Bello, F. & Adcock, I. M. Corticosteroid resistance in asthma: cellular and molecular mechanisms. Mol. Asp. Med. 85, 100969 (2022).","journal-title":"Mol. Asp. Med."},{"key":"61114_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00109-020-01873-3","volume":"98","author":"S Lea","year":"2020","unstructured":"Lea, S. et al. P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells. J. Mol. Med. 98, 361\u2013374 (2020).","journal-title":"J. Mol. Med."},{"key":"61114_CR14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41573-023-00750-1","volume":"22","author":"P Kolkhir","year":"2023","unstructured":"Kolkhir, P. et al. Type 2 chronic inflammatory diseases: targets, therapies and unmet needs. Nat. Rev. Drug Discov. 22, 743\u2013767 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"61114_CR15","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/all.14221","volume":"75","author":"I Agache","year":"2020","unstructured":"Agache, I. et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma: a systematic review for the EAACI Guidelines\u2014recommendations on the use of biologicals in severe asthma. Allergy 75, 1023\u20131042 (2020).","journal-title":"Allergy"},{"key":"61114_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin, S. et al. mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduct. Target. Ther. 7, 166 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"61114_CR17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4278","volume":"13","author":"U Sahin","year":"2014","unstructured":"Sahin, U., Karik\u00f3, K. & T\u00fcreci, \u00d6. mRNA-based therapeutics\u2014developing a new class of drugs. Nat. Rev. Drug Discov. 13, 759\u2013780 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"61114_CR18","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1067\/mai.2002.122712","volume":"109","author":"SJ Szefler","year":"2002","unstructured":"Szefler, S. J. & Eigen, H. Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma. J. Allergy Clin. Immunol. 109, 730\u2013742 (2002).","journal-title":"J. Allergy Clin. Immunol."},{"key":"61114_CR19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/ni.1892","volume":"11","author":"H Kim","year":"2010","unstructured":"Kim, H., DeKruyff, R. & Umetsu, D. The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat. Immunol. 11, 577\u2013584 (2010).","journal-title":"Nat. Immunol."},{"key":"61114_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41392-019-0079-0","volume":"4","author":"SS Athari","year":"2019","unstructured":"Athari, S. S. Targeting cell signaling in allergic asthma. Signal Transduct. Target. Ther. 4, 45 (2019).","journal-title":"Signal Transduct. Target. Ther."},{"key":"61114_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51056-8","volume":"15","author":"X Bai","year":"2024","unstructured":"Bai, X. et al. Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy. Nat. Commun. 15, 6844 (2024).","journal-title":"Nat. Commun."},{"key":"61114_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn7162","volume":"8","author":"X Bai","year":"2022","unstructured":"Bai, X. et al. Inhaled siRNA nanoparticles targeting IL11 inhibit lung fibrosis and improve pulmonary function post-bleomycin challenge. Sci. Adv. 8, eabn7162 (2022).","journal-title":"Sci. Adv."},{"key":"61114_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0014-2999(01)01192-X","volume":"425","author":"N Bandi","year":"2001","unstructured":"Bandi, N. & Kompella, U. B. Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells. Eur. J. Pharmacol. 425, 109\u2013116 (2001).","journal-title":"Eur. J. Pharmacol."},{"key":"61114_CR24","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1111\/j.1432-1033.2004.04342.x","volume":"271","author":"JE Chivers","year":"2004","unstructured":"Chivers, J. E. et al. Differential effects of RU486 reveal distinct mechanisms for glucocorticoid repression of prostaglandin E release. Eur. J. Biochem. 271, 4042\u20134052 (2004).","journal-title":"Eur. J. Biochem."},{"key":"61114_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.phrs.2014.01.002","volume":"81","author":"E Corsini","year":"2014","unstructured":"Corsini, E. et al. Corticosteroids modulate the expression of the PKC-anchoring protein RACK-1 and cytokine release in THP-1 cells. Pharmacol. Res. 81, 10\u201316 (2014).","journal-title":"Pharmacol. Res."},{"key":"61114_CR26","doi-asserted-by":"publisher","first-page":"18936","DOI":"10.1021\/acsnano.2c07822","volume":"16","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. Enzyme-catalyzed one-step synthesis of ionizable cationic lipids for lipid nanoparticle-based mRNA COVID-19 vaccines. ACS Nano 16, 18936\u201318950 (2022).","journal-title":"ACS Nano"},{"key":"61114_CR27","doi-asserted-by":"publisher","first-page":"24075","DOI":"10.1073\/pnas.1908052116","volume":"116","author":"DM Mauger","year":"2019","unstructured":"Mauger, D. M. et al. mRNA structure regulates protein expression through changes in functional half-life. Proc. Natl Acad. Sci. USA 116, 24075\u201324083 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"61114_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41565-023-01548-3","volume":"19","author":"AY Jiang","year":"2024","unstructured":"Jiang, A. Y. et al. Combinatorial development of nebulized mRNA delivery formulations for the lungs. Nat. Nanotechnol. 19, 364\u2013375 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"61114_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ni1558","volume":"9","author":"C Sokol","year":"2008","unstructured":"Sokol, C. et al. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat. Immunol. 9, 310\u2013318 (2008).","journal-title":"Nat. Immunol."},{"key":"61114_CR30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1517\/14728222.2014.915314","volume":"18","author":"B Watson","year":"2014","unstructured":"Watson, B. & Gauvreau, G. M. Thymic stromal lymphopoietin: a central regulator of allergic asthma. Expert Opin. Ther. Targets 18, 771\u2013785 (2014).","journal-title":"Expert Opin. Ther. Targets"},{"key":"61114_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53914-x","volume":"15","author":"S Liu","year":"2024","unstructured":"Liu, S. et al. Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination. Nat. Commun. 15, 9471 (2024).","journal-title":"Nat. Commun."},{"key":"61114_CR32","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jaci.2020.09.032","volume":"147","author":"H Li","year":"2021","unstructured":"Li, H. et al. Single-cell transcriptomic analysis reveals key immune cell phenotypes in the lungs of patients with asthma exacerbation. J. Allergy Clin. Immunol. 147, 941\u2013954 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"61114_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53038-2","volume":"15","author":"S Han","year":"2024","unstructured":"Han, S. et al. Distinctive CD39+CD9+ lung interstitial macrophages suppress IL-23\/Th17-mediated neutrophilic asthma by inhibiting NETosis. Nat. Commun. 15, 8628 (2024).","journal-title":"Nat. Commun."},{"key":"61114_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41577-020-00477-9","volume":"21","author":"RJ Hewitt","year":"2021","unstructured":"Hewitt, R. J. & Lloyd, C. M. Regulation of immune responses by the airway epithelial cell landscape. Nat. Rev. Immunol. 21, 347\u2013362 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"61114_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3675","volume":"4","author":"H Kabata","year":"2013","unstructured":"Kabata, H. et al. Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation. Nat. Commun. 4, 2675 (2013).","journal-title":"Nat. Commun."},{"key":"61114_CR36","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41591-022-01714-5","volume":"28","author":"P Kachroo","year":"2022","unstructured":"Kachroo, P. et al. Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma. Nat. Med. 28, 814\u2013822 (2022).","journal-title":"Nat. Med."},{"key":"61114_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd2893","volume":"373","author":"R Cho","year":"2021","unstructured":"Cho, R. et al. Thymic stromal lymphopoietin induces adipose loss through sebum hypersecretion. Science 373, eabd2893 (2021).","journal-title":"Science"},{"key":"61114_CR38","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s40265-020-01273-4","volume":"80","author":"MG Matera","year":"2020","unstructured":"Matera, M. G., Rogliani, P., Calzetta, L. & Cazzola, M. TSLP inhibitors for asthma: current status and future prospects. Drugs 80, 449\u2013458 (2020).","journal-title":"Drugs"},{"key":"61114_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","volume":"6","author":"D Zheng","year":"2020","unstructured":"Zheng, D., Liwinski, T. & Elinav, E. Inflammasome activation and regulation: toward a better understanding of complex mechanisms. Cell Discov. 6, 36 (2020).","journal-title":"Cell Discov."},{"key":"61114_CR40","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jaci.2013.04.012","volume":"132","author":"S Saglani","year":"2013","unstructured":"Saglani, S. et al. IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. J. Allergy Clin. Immunol. 132, 676\u2013685.e13 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"61114_CR41","doi-asserted-by":"publisher","first-page":"337ra65","DOI":"10.1126\/scitranslmed.aaf1938","volume":"8","author":"KM Vannella","year":"2016","unstructured":"Vannella, K. M. et al. Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis. Sci. Transl. Med. 8, 337ra65 (2016).","journal-title":"Sci. Transl. Med."},{"key":"61114_CR42","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s40265-022-01679-2","volume":"82","author":"SM Hoy","year":"2022","unstructured":"Hoy, S. M. Tezepelumab: first approval. Drugs 82, 461\u2013468 (2022).","journal-title":"Drugs"},{"key":"61114_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2022.102184","volume":"78","author":"PM O\u2019Byrne","year":"2023","unstructured":"O\u2019Byrne, P. M. et al. Development of an inhaled anti-TSLP therapy for asthma. Pulm. Pharmacol. Ther. 78, 102184 (2023).","journal-title":"Pulm. Pharmacol. Ther."},{"key":"61114_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrd2153","volume":"6","author":"J Patton","year":"2007","unstructured":"Patton, J. & Byron, P. Inhaling medicines: delivering drugs to the body through the lungs. Nat. Rev. Drug Discov. 6, 67\u201374 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"61114_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-022-02240-1","volume":"23","author":"L Ma","year":"2022","unstructured":"Ma, L. et al. Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthma. Respir. Res. 23, 316 (2022).","journal-title":"Respir. Res."},{"key":"61114_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68671-2","volume":"10","author":"N Mazarakis","year":"2020","unstructured":"Mazarakis, N. et al. Investigation of molecular mechanisms of experimental compounds in murine models of chronic allergic airways disease using synchrotron Fourier-transform infrared microspectroscopy. Sci. Rep. 10, 11713 (2020).","journal-title":"Sci. Rep."},{"key":"61114_CR47","doi-asserted-by":"publisher","first-page":"e20211828","DOI":"10.1084\/jem.20211828","volume":"219","author":"H Zhang","year":"2022","unstructured":"Zhang, H. et al. AMFR drives allergic asthma development by promoting alveolar macrophage-derived GM-CSF production. J. Exp. Med. 219, e20211828 (2022).","journal-title":"J. Exp. Med."},{"key":"61114_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44179-x","volume":"14","author":"J Quan","year":"2023","unstructured":"Quan, J. et al. Epithelial SIRT6 governs IL-17A pathogenicity and drives allergic airway inflammation and remodeling. Nat. Commun. 14, 8525 (2023).","journal-title":"Nat. Commun."},{"key":"61114_CR49","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1378\/chest.129.3.661","volume":"129","author":"LP Boulet","year":"2006","unstructured":"Boulet, L. P. et al. Smoking and asthma: clinical and radiologic features, lung function, and airway inflammation. Chest 129, 661\u2013668 (2006).","journal-title":"Chest"},{"key":"61114_CR50","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3390\/cells12071091","volume":"12","author":"JS Woodrow","year":"2023","unstructured":"Woodrow, J. S. et al. Asthma: the use of animal models and their translational utility. Cells 12, 1091 (2023).","journal-title":"Cells"},{"key":"61114_CR51","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41590-024-01834-9","volume":"25","author":"G Jin","year":"2024","unstructured":"Jin, G. et al. A single infusion of engineered long-lived and multifunctional T cells confers durable remission of asthma in mice. Nat. Immunol. 25, 1059\u20131072 (2024).","journal-title":"Nat. Immunol."},{"key":"61114_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17972-1","volume":"11","author":"S Wu","year":"2020","unstructured":"Wu, S. et al. A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge. Nat. Commun. 11, 4081 (2020).","journal-title":"Nat. Commun."},{"key":"61114_CR53","doi-asserted-by":"publisher","unstructured":"Chen, H. et al. Chemical and topological design of multicapped mRNA and capped circular RNA to augment translation. Nature Biotechnology https:\/\/doi.org\/10.1038\/s41587-024-02393-y (2024).","DOI":"10.1038\/s41587-024-02393-y"},{"key":"61114_CR54","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41590-018-0297-6","volume":"20","author":"P Zhu","year":"2019","unstructured":"Zhu, P. et al. IL-13 secreted by ILC2s promotes the self-renewal of intestinal stem cells through circular RNA circPan3. Nat. Immunol. 20, 183\u2013194 (2019).","journal-title":"Nat. Immunol."},{"key":"61114_CR55","doi-asserted-by":"publisher","DOI":"10.34133\/2022\/9816234","volume":"2022","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Localized myocardial anti-inflammatory effects of temperature-sensitive budesonide nanoparticles during radiofrequency catheter ablation. Research 2022, 9816234 (2022).","journal-title":"Research"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61114-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61114-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61114-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:53:23Z","timestamp":1751381603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61114-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["61114"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-61114-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6013"}}